Attachments
- Original document
- Permalink
Disclaimer
Veracyte Inc. published this content on 03 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2021 12:12:06 UTC.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.42 USD | +1.16% |
|
+5.90% | -25.66% |
04-15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
02-26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
Attachments
Disclaimer
Veracyte Inc. published this content on 03 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2021 12:12:06 UTC.
1st Jan change | Capi. | |
---|---|---|
-25.66% | 1.54B | |
-16.00% | 11.13B | |
+65.25% | 3.6B | |
-30.20% | 2.26B | |
-14.31% | 2.16B | |
+37.48% | 1.17B | |
-2.40% | 744M | |
-38.47% | 432M | |
+13.72% | 357M | |
+15.53% | 225M |